Arch Therapeutics Inc (ARTH)
1.13
-0.01
(-0.62%)
USD |
OTCM |
May 31, 16:00
Arch Therapeutics Enterprise Value: 11.89M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 11.89M |
| May 30, 2024 | 11.93M |
| May 29, 2024 | 11.54M |
| May 28, 2024 | 12.16M |
| May 24, 2024 | 12.46M |
| May 23, 2024 | 13.49M |
| May 22, 2024 | 13.45M |
| May 21, 2024 | 13.45M |
| May 20, 2024 | 13.45M |
| May 17, 2024 | 11.54M |
| May 16, 2024 | 11.49M |
| May 15, 2024 | 11.49M |
| May 14, 2024 | 11.49M |
| May 13, 2024 | 11.49M |
| May 10, 2024 | 11.49M |
| May 09, 2024 | 11.49M |
| May 08, 2024 | 11.09M |
| May 07, 2024 | 11.09M |
| May 06, 2024 | 11.09M |
| May 03, 2024 | 10.98M |
| May 02, 2024 | 11.36M |
| May 01, 2024 | 12.12M |
| April 30, 2024 | 12.12M |
| April 29, 2024 | 12.12M |
| April 26, 2024 | 12.12M |
| Date | Value |
|---|---|
| April 25, 2024 | 12.12M |
| April 24, 2024 | 12.12M |
| April 23, 2024 | 11.94M |
| April 22, 2024 | 12.12M |
| April 19, 2024 | 11.54M |
| April 18, 2024 | 12.12M |
| April 17, 2024 | 12.03M |
| April 16, 2024 | 11.84M |
| April 15, 2024 | 11.89M |
| April 12, 2024 | 13.58M |
| April 11, 2024 | 13.45M |
| April 10, 2024 | 13.94M |
| April 09, 2024 | 14.25M |
| April 08, 2024 | 14.25M |
| April 05, 2024 | 14.43M |
| April 04, 2024 | 14.43M |
| April 03, 2024 | 14.83M |
| April 02, 2024 | 15.09M |
| April 01, 2024 | 14.87M |
| March 31, 2024 | 15.58M |
| March 28, 2024 | 16.23M |
| March 27, 2024 | 15.54M |
| March 26, 2024 | 16.14M |
| March 25, 2024 | 17.09M |
| March 22, 2024 | 17.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.707M
Minimum
Sep 07 2023
60.75M
Maximum
Jun 10 2019
23.80M
Average
23.55M
Median
Nov 04 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 680.29M |
| Electromed Inc | 114.83M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
| Senseonics Holdings Inc | 181.47M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.469M |
| Revenue (Quarterly) | 0.0319M |
| Total Expenses (Quarterly) | 0.9086M |
| EPS Diluted (Quarterly) | -0.33 |
| Gross Profit Margin (Quarterly) | 32.36% |
| Profit Margin (Quarterly) | -4.61K% |
| Earnings Yield | -251.7% |
| Normalized Earnings Yield | -251.68 |